Table of Contents - WOC 2012

WOC2012 Abstract Book
FR-GLA-SU 300 (4)
Surface Oculaire du Glaucomateux
Baudouin Christophe (1)
1. Quinze-Vingts Hospital
Many experimental and clinical studies have largely shown that the long-term
use of topical drugs may cause ocular discomfort, tear film instability,
conjunctival inflammation, subconjunctival fibrosis, corneal surface impairment,
and the potential risk of failure for further glaucoma surgery. The respective
roles of the active compound and the preservative in inducing such toxic and/
or proinflammatory effects are still being debated, but the most frequently used
preservative, benzalkonium chloride, has consistently demonstrated its toxic
effects in laboratory, experimental, and clinical studies.
FR-GLA-SU 300 (5)
Apport du CSLO dans les Hypertonies Oculaires
Tounsi Lilia
1. Charles Nicolle University Hospital
This nonrandomized, prospective, comparative study compares the optic
nerve head (ONH) topographic measurements between a group of ocular
hypertensive eyes (48 eyes)and a control normal group (54 eyes) . Our study
showed significant lowering in four stereometric parameters: RV, HVC, RNFL
th, RNFL csa in ocular hypertensive eyes compared to normal eyes. Imaging
findings of the ONH using the HRT might contribute to early diagnosis of ocular
hypertension converting to glaucoma.
FR-GLA-SU 300 (6)
Quand les Dernières Fibres Doivent être Préservées
Mermoud Andre (1)
1. Visionplus SA
Abstract not available
FR-GLA-SU 300 (7)
Les Challenges du Glaucome en Afrique en 2012
Ouertani Amel (1)
1. MEACO
Abstract not available
End-stage Glaucoma: Challenges of Clinical Assessment, Surgical
Versus Medical Treatment, and Visual Prognosis
Sun 19 Feb 10:30 - 12:00 Capital Suite 15
CO-GLA-SU 301
End-stage Glaucoma: Challenges of Clinical Assessment, Surgical
versus Medical Treatment, and Visual Prognosis
Eid Tarek (1,2) , Mustafa Ahmad (3) , El-Nahry Gehad (3) , Yaqub Moustafa (4)
1. Magrabi Eye and Ear Center
2. Ophthalmology Department, Tanta University
3. Ophthalmology Department, Cairo University
4. Jarash Internatioopnal Speciality Hospital
Objectives: The course aims to instruct attendees about how to deal with a
patient with end-stage glaucoma in terms of clinical assessment of diagnostic
and progression parameters and various modalities of treatment of such patient
and the impact of treatment and disease progression on visual prognosis.
Summary of content: The course will discuss an important topic that carries a
major challenge in many regions of the world where a plenty of patients are
seen for the first time with a severe form of glaucoma (end-stage). What
are the criteria of defining advanced to end-stage glaucoma? What further
investigations should be performed for these patients? And the evaluation
of progression rates and continued visual loss. Evaluation and visibility of
medical treatment with its recent advances will be addressed and adherence
to treatment plan and follow-up schedule. Surgical treatment of these patients
will be discussed in details with various techniques to achieve a very low target
pressure, surgical hazards, wipe out phenomenon, and long-term glaucoma
stability versus continued progression and visual loss in this highly advanced
disease.
Target Audience: General Ophthalmologists and Glaucoma Specialists
Educational Level: Intermediate and Advanced
290
Cataract Surgery in Glaucoma: Adapting the Solutions to the
Patients
Sun 19 Feb 13:30 - 15:00 Hall 7 - Tokyo Hall
IS-GLA-SU 302 (1)
Panel Discussion
Tomey Karim (1)
1. Rizk Hospital
Discussion:
• Combined surgery vs. sequential surgery
• Cataract surgery after filtration surgery
• Filtration surgery after cataract surgery
• Combined surgery: which glaucoma procedure for which patient?
• Exfoliation: is earlier cataract surgery a better option?
• Angle closure and lens surgery
• Phacoemulsification after acute angle closure attack
• Cataract surgery in POAG: precautions
IS-GLA-SU 302 (2)
Panel Discussion
Yaqub Moustafa (1)
1. Jarash International Speciality Hospital
Abstract not available
IS-GLA-SU 302 (3)
Panel Discussion
Hommer Anton (1)
1. Hera Hospital
Abstract not available
IS-GLA-SU 302 (4)
Panel Discussion
Susanna Jr. Remo (1)
1. Faculdade de Medicina da Universidade de Sao Paulo
Abstract not available
IS-GLA-SU 302 (5)
Panel Discussion
Traverso Carlo (1)
1. Clinica Oculistica Di.N.O.G. University of Genova
Abstract not available
IS-GLA-SU 302 (6)
Panel Discussion
Zeyen Thierry (1)
1. University Hospitals Leuven
Abstract not available
IS-GLA-SU 302 (7)
Panel Discussion
Topouzis Fotis (1)
1. Aristotle University of Thessaloniki
Abstract not available